Harvey M. Solomon
- Molecular Biology
- Pharmacology top 5%
- Pharmacology top 2%
- Oncology top 10%
- Pediatrics, Perinatology and Child Health top 5%
- Co-authors
- John J. SchrogieWilliam B. AbramsGeorge F. JohnsonPhilip D. ZieveZane N. GautLewis S. SchankerAaron H. AntonJulius R. Krevans
- Topics
- Antibiotics Pharmacokinetics and Efficacy (13 papers)Analytical Methods in Pharmaceuticals (8 papers)Metabolism and Genetic Disorders (6 papers)
- Cited by
- PharmacologyAnalytical Chemistry
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
Harvey M. Solomon
74 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 117
- Molecular Biology 513
- Pharmacology 272
- Pharmacology 264
- Oncology 234
- Pediatrics, Perinatology and Child Health 212
Countries citing papers authored by Harvey M. Solomon
This map shows the geographic impact of Harvey M. Solomon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harvey M. Solomon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harvey M. Solomon more than expected).
Fields of papers citing papers by Harvey M. Solomon
This network shows the impact of papers produced by Harvey M. Solomon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harvey M. Solomon. The network helps show where Harvey M. Solomon may publish in the future.
Co-authorship network of co-authors of Harvey M. Solomon
This figure shows the co-authorship network connecting the top 25 collaborators of Harvey M. Solomon. A scholar is included among the top collaborators of Harvey M. Solomon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harvey M. Solomon. Harvey M. Solomon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 18 | |
| 2 | 3 | |
| 3 | 1 | |
| 4 | 9 | |
| 5 | 14 | |
| 6 | 15 | |
| 7 | 34 | |
| 8 | 65 | |
| 9 | Drug-protein binding | 61 |
| 10 | 25 | |
| 11 | 53 | |
| 12 | 13 | |
| 13 | 4 | |
| 14 | 16 | |
| 15 | 47 | |
| 16 | 46 | |
| 17 | 64 | |
| 18 | The intestinal absorption of vitamin B6 compounds by the rat and hamster. | 18 |
| 19 | 39 | |
| 20 | 2 |
About Harvey M. Solomon
Harvey M. Solomon is a scholar working on Pharmacology, Pharmacology and Clinical Biochemistry, having authored 76 papers that have together received 1.7k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (13 papers), Analytical Methods in Pharmaceuticals (8 papers) and Metabolism and Genetic Disorders (6 papers). The work is most often cited by research in Pharmacology (264 citations), Pharmacology (272 citations) and Analytical Chemistry (150 citations). Harvey M. Solomon has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include John J. Schrogie, William B. Abrams, George F. Johnson, Philip D. Zieve, Zane N. Gaut, Lewis S. Schanker, Aaron H. Anton, Julius R. Krevans, Daniel Jackson and Steven D. Reich. Their work appears in journals such as Science, New England Journal of Medicine and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.